Top Upgrades
- Goldman Sachs upgraded 3M Co MMM from Sell to Neutral. 3M shares rose 0.23 percent to $235.20 in pre-market trading.
- Wedbush upgraded Capital One Financial Corp. COF from Underperform to Neutral. Capital One shares fell 0.22 percent to close at $89.52 on Tuesday.
- Wells Fargo upgraded Science Applications International Corp SAIC from Market Perform to Outperform. Science Applications shares rose 1.12 percent to close at $ 72.19 on Tuesday.
- BMO Capital upgraded Biogen Inc BIIB from Market Perform to Outperform. Biogen shares gained 0.13 percent to $316.15 in pre-market trading.
- Baird upgraded Illumina, Inc. ILMN from Neutral to Outperform. Illumina shares climbed 1.98 percent to $215.00 in pre-market trading.
- Analysts at Evercore ISI Group upgraded United Continental Holdings Inc UAL from In-Line to Outperform. United Continental shares gained 0.95 percent to $60.48 in pre-market trading.
- Analysts at Mizuho Securities upgraded PulteGroup, Inc. PHM from Underperform to Neutral. PulteGroup shares gained 2.76 percent to close at $28.68 on Tuesday.
- Wells Fargo upgraded Leidos Holdings, Inc. LDOS from Market Perform to Outperform. Leidos Holdings shares fell 0.86 percent to close at $61.24 on Tuesday.
Top Downgrades
- Morgan Stanley downgraded General Motors Company GM from Overweight to Equal-Weight. GM shares fell 1.46 percent to $45.80 in pre-market trading.
- Analysts at BMO Capital downgraded Polaris Industries Inc. PII from Outperform to Market Perform. Polaris Industries shares fell 1.27 percent to $121.61 in pre-market trading.
- Analysts at Barclays downgraded Novartis AG (ADR) NVS from Equal-Weight to Underweight. Novartis shares fell 0.52 percent to $82.70 in pre-market trading.
- Raymond James downgraded Masco Corp MAS from Outperform to Market Perform. Masco shares rose 1.77 percent to close at $40.83 on Wednesday.
- Baird downgraded Acadia Healthcare Company Inc ACHC from Outperform to Neutral. Acadia Healthcare shares fell 21.69 percent to $34.55 in pre-market trading.
- Needham downgraded HealthStream, Inc. HSTM from Buy to Hold. HealthStream shares declined 2.37 percent to close at $23.86 on Wednesday.
- Compass Point downgraded Discover Financial Services DFS from Buy to Neutral. Discover Financial shares fell 2.79 percent to $65.51 in pre-market trading.
- Raymond James downgraded Rent-A-Center Inc RCII from Strong Buy to Market Perform. Rent-A-Center shares fell 5.31 percent to $9.99 in pre-market trading.
- Wells Fargo downgraded Hanesbrands Inc. HBI from Outperform to Market Perform. Hanesbrands shares declined 1.04 percent to $22.87 in pre-market trading.
- Telsey Advisory Group downgraded Chipotle Mexican Grill, Inc. CMG from Outperform to Market Perform. Chipotle shares fell 11.81 percent to $286.00 in pre-market trading.
Top Initiations
- UBS initiated coverage on Toll Brothers Inc TOL with a Buy rating. The price target for Toll Brothers is set to $50 Toll Brothers shares closed at $44.61 on Tuesday.
- Cantor Fitzgerald initiated coverage on Aldeyra Therapeutics Inc ALDX with an Overweight rating. The price target for Aldeyra Therapeutics is set to $22. Aldeyra Therapeutics shares closed at $6.20 on Tuesday.
- BMO Capital initiated coverage on Albemarle Corporation ALB with an Outperform rating. The price target for Albemarle is set to $160. Albemarle shares closed at $138.72 on Tuesday.
- Analysts at Roth Capital initiated coverage on RumbleON, Inc. RMBL with a Buy rating. The price target for RumbleON is set to $7.75. RumbleON shares closed at $4.50 on Tuesday.
- Analysts at UBS initiated coverage of Lennar Corporation LEN with a Buy rating. The price target for Lennar is set to $77. Lennar shares closed at $58.01 on Tuesday.
- Analysts at Roth Capital initiated coverage on Las Vegas Sands Corp. LVS with a Buy rating. The price target for Las Vegas Sands is set to $69. Las Vegas Sands shares closed at $63.15 on Tuesday.
- Analysts at HSBC initiated coverage on Apple Inc. AAPL with a Buy rating. The price target for Apple is set to $193. Apple shares closed at $157.10 on Tuesday.
- UBS initiated coverage on D. R. Horton Inc DHI with a Buy rating. The price target for D. R. Horton is set to $50. D. R. Horton shares closed at $43.32 on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in